| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Apr―17 |
A Bayesian approach for studying COVID-19 contagion dynamics in Algeria using a Poisson autoregressive (PAR) model |
Ahmed Hamimes, Hani Amir Aouissi, Feriel Kheira Kebaili, Zeinab A. Kasemy |
| 2 |
[GO] |
2024―Nov―17 |
Latent class analysis of post-acute sequelae of SARS-CoV-2 infection |
Xiaowu Sun, Jonathan P. DeShazo, Laura Anatale-Tardiff, Manuela Di Fusco, Kristen E. Allen, Thomas M. Porter, Henriette Coetzer, Santiago M.C Lopez, Laura Puzniak, Joseph C. Cappelleri |
| 3 |
[GO] |
2024―Mrz―22 |
Association of the medication protocols and longitudinal change of COVID-19 symptoms: a hospital-based mixed-statistical methods study |
Zahra Rezaei Ghahroodi, Samaneh Eftekhari Mahabadi, Alireza Esberizi, Ramin Sami, Marjan Mansourian |
| 4 |
[GO] |
2023―Jan―31 |
Assessing adverse events in clinical trials during the era of the COVID-19 pandemic |
James Buchanan, Mengchun Li, Barbara Hendrickson, Parul Bhargava, Satrajit Roychoudhury |
| 5 |
[GO] |
2021―Sep―23 |
Power and sample size calculation for the win odds test: application to an ordinal endpoint in COVID-19 trials |
Samvel B. Gasparyan, Elaine K. Kowalewski, Folke Folkvaljon, Olof Bengtsson, Joan Buenconsejo, John Adler, Gary G. Koch |
| 6 |
[GO] |
2021―Aug―18 |
Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment Trials |
Sujatro Chakladar, Ran Liao, Margaret Gamalo |
|
